Literature DB >> 6668485

A comparison of the quality of participation of community affiliates and that of universities in the Northern California Oncology Group.

M M Koretz, P M Jackson, F M Torti, S K Carter.   

Abstract

The quality of participation in the performance of clinical trials of university members and community affiliates of the Northern California Oncology Group is evaluated and compared. The data, based on 738 patients on 33 protocols, were collected during a one year period, July 1, 1980--June 30, 1981. The comparisons are made on three types of criteria: accrual distribution, with respect to study phase and modality multiplicity; data quality, generally reflecting protocol adherence; and data completeness. The performance of the community affiliates was found to equal or surpass that of the university members in most measures. Therefore, it is concluded that the community affiliates are functioning as full and valuable participants in the Northern California Oncology Group.

Entities:  

Mesh:

Year:  1983        PMID: 6668485     DOI: 10.1200/JCO.1983.1.10.640

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  3 in total

1.  Clinical trial performance of community- vs university-based practices in the submacular surgery trials (SST): SST report no. 2.

Authors:  Neil M Bressler; Barbara S Hawkins; Susan B Bressler; Päivi H Miskala; Marta J Marsh
Journal:  Arch Ophthalmol       Date:  2004-06

2.  T-HELPER: automated support for community-based clinical research.

Authors:  M A Musen; R W Carlson; L M Fagan; S C Deresinski; E H Shortliffe
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1992

3.  Approach to High Volume Enrollment in Clinical Research: Experiences from an All of Us Research Program Site.

Authors:  Titilayo O Ilori; Emma Viera; Jillian Wilson; Francisco Moreno; Usha Menon; John Ehiri; Rachele Peterson; Tejo Vemulapalli; Sara C StimsonRiahi; Cecilia Rosales; Elizabeth Calhoun; Amanda Sokan; Jason H Karnes; Eric Reiman; Akinlolu Ojo; Andreas Theodorou; Tammy Ojo
Journal:  Clin Transl Sci       Date:  2020-03-17       Impact factor: 4.689

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.